NCT03103789
Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device
Enrolling by Invitation
Not specifiedAges 18–99ObservationalVanderbilt University Medical CenterInvestigator-initiated
~75 participants
Updated 2026-06-26 on ClinicalTrials.gov
What's tested:single catheter mucosal impedance testingballoon assembly mucosal impedance testing
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
mucosal impedance values
Measured over Values will be obtained at conclusion of EGD, an expected average of 6 minutes
Conditions
Where it's being run
1 sites across 1 statesTennessee1
Study leadership
- Michael Vaezi, MD, PhD · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients who are undergoing standard of care EGD with or without BRAVO pH capsule placement
Exclusion
Age less than 18 years old
Patients unable to give informed consent
Use of acid suppressive therapy within last 10 days
Known history of Barrett's esophagus or gastric surgery, other than non-functioning (slipped) Nissen fundoplication
What this trial measures
- mucosal impedance valuesValues will be obtained at conclusion of EGD, an expected average of 6 minutes
compare the mucosal impedance values obtained from single channel catheter and balloon assembly catheter in GERD patients and controls